Collaboration Live

November 10, 2020 updated by: Philips Clinical & Medical Affairs Global

Collaboration Live Clinical Study

Collaboration Live is a prospective, single-arm clinical study of subjects who provide written consent. Subjects are scanned using a Philips EPIQ 5 or EPIQ 7 Ultrasound System equipped with Collaboration Live software. The study investigator will evaluate performance of the Collaboration Live tool with regard to performance of conferencing, sharing and control capabilities. Adverse events will be reported and the study investigator will assess potential relationship to the study device or study procedure. Additionally, the utility of Collaboration Live in remote consult of study patients will be evaluated. No patient follow-up beyond the initial consultation will be conducted with the Collaboration Live software solution.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Mexico
      • Albuquerque, New Mexico, United States, 87106
        • Perinatal Associates of New Mexico
      • Rio Rancho, New Mexico, United States, 87124
        • Perinatal Associates of New Mexico
      • Santa Fe, New Mexico, United States, 87505
        • Perinatal Associates of New Mexico

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Subject is at least 18 years of age
  • Subject in indicated for a routine Obstetrics/Gynecology ultrasound examination at the site.
  • Subject is willing and capable of providing informed consent and participating in this study

Exclusion Criteria:

  • A medical condition or co-morbidity that would be unduly affected by study participation, per investigator discretion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Experimental - Collaboration Live software
Collaboration Live is a non-diagnostic software solution intended for use with Philips (Philips Ultrasound, 22100 Bothell Everett Highway, Bothell, Washington 98021) EPIQ and Affiniti Series Ultrasound Systems (software version 5.0.2) that allows users to communicate (by text, voice, screen share, webcam video and remote takeover) from an ultrasound system or workstation to a remote destination.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Clinically Acceptable Performance of Remote Control Functionality
Time Frame: Intra-procedural (1 day)
The system responds to the remote input as intended and without a delay interfering with the conduct of the exam. Additionally, a clinically acceptable exam would result in no adverse events related to the control feature
Intra-procedural (1 day)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Technical Issues
Time Frame: Intra-procedural (1 day)
Number of subjects for which device deficiencies are reported
Intra-procedural (1 day)
Success Rates for Key Tasks in the Collaborative Exam
Time Frame: Intra-procedural (1 day)
Establishing the remote connection, establishing text chat, establishing voice call, establishing webcam feed, establishing screen share, establishing remote control
Intra-procedural (1 day)
Travel Reduction Attributable to Use of Collaboration Live
Time Frame: Intra-procedural (1 day)
Distance between the scanning facility and the investigator's location will be recorded (in miles).
Intra-procedural (1 day)
Ease of Use
Time Frame: Intra-procedural (1 day)
5-point (Likert) scale data will be reported by the investigator.( 5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree)
Intra-procedural (1 day)
User Feedback Regarding Streaming, Image Quality and Overall Experience
Time Frame: Intra-procedural (1 day)
5-point (Likert) scale data will be reported by the investigator. ( 5 = Very good, 4 = Good, 3 = Acceptable, 2 = Poor, 1 = Very Poor)
Intra-procedural (1 day)
Patient Feedback Regarding Remote Consultation
Time Frame: 1 day
Tele-medicine Satisfaction Questionnaire
1 day
Impact of Remote Consultation on Reimbursement
Time Frame: 30 days
Submitted charges and reimbursement rates for remote patient consultation data will be recorded and compared to standard rates for in-person consultation
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 9, 2020

Primary Completion (Actual)

February 20, 2020

Study Completion (Actual)

February 20, 2020

Study Registration Dates

First Submitted

January 21, 2020

First Submitted That Met QC Criteria

January 24, 2020

First Posted (Actual)

January 28, 2020

Study Record Updates

Last Update Posted (Actual)

December 4, 2020

Last Update Submitted That Met QC Criteria

November 10, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • US-GIS-10649

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Clinical Trials on Non-diagnostic software solution

Subscribe